FY2029 Earnings Estimate for ZVRA Issued By Roth Capital
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Zevra Therapeutics in a note issued to investors on Sunday, February 9th. Roth Capital analyst J. Aschoff expects that the company will post earnings per share of $2.26 for the year. The consensus […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Zevra Therapeutics in a note issued to investors on Sunday, February 9th. Roth Capital analyst J. Aschoff expects that the company will post earnings per share of $2.26 for the year. The consensus […]
